Lance Stewart, Ph.D. MBA, brings over 18 years of experience in drug discovery research, life sciences partnering and entrepreneurial start-up activities. He co-founded Emerald BioStructures in 1998 as a UW spin out company focused on collaborative drug discovery research (now Beryllium). He led Emerald’s growth as a business unit within two publicly traded companies and the successful spinout from deCODE genetics in 2009. Dr. Stewart has managed several multi-year collaborations in technology development and structure-based drug design. While at Emerald and deCODE, he oversaw contract research activities in structural elucidation of protein-drug complexes that supported the discovery of eight investigational new drug candidates, including molecules for improvement of memory, treatment of spinal muscular atrophy, cancer, inflammation, and viral and bacterial infection. In 2005, he co-founded Emerald BioSystems to commercialize reagent systems (now a Rigaku company) and protein purification / crystallization instruments (now Protein Biosolutions) which were developed with funding from the NIH’s Protein Structure Initiative. From 2005 to 2012, Lance served as the co-principal investigator for the Seattle Structural Genomics Center for Infectious Disease, an NIAID funded collaboration which has solved the 3D structures of over 600 infectious disease protein targets. He subsequently served as the Sr. Director of Alliances at the Allen Institute for Brain Science, where he co-founded the NorthWest NeuroNeighborhood.
Lance also serves on the board of directors for Tetra Discovery Partners, advisor to M3 Biotechnology and Beryllium, and is a member of the WINGS Washington medical technology angel investor network. He holds a bachelor’s degree in biology from McMaster University and a doctorate in biochemistry and virology from Cornell University. He also earned an Executive Master of Business Administration from the Foster School at the University of Washington. He has co-authored 75 peer reviewed scientific publications and five book chapters, and is inventor on nine issued U.S. patents.Lance Stewart, Ph.D. MBA